Brief: Kinnate Biopharma Inc In Collaboration With Guardant Health Announces Initial Findings From BRAF Kinase Alteration Genomic Landscape And Real-World Clinical Outcomes Study
01/11/2021 13:50
Nov 1 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* KINNATE BIOPHARMA INC. IN COLLABORATION WITH GUARDANT
HEALTH
ANNOUNCES INITIAL FINDINGS FROM BRAF KINASE ALTERATION GENOMIC
LANDSCAPE AND REAL-WORLD CLINICAL OUTCOMES STUDY
Source text for Eikon: ID:nGNX33V7pw
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview